No preclinical rationale for IGF1R directed therapy in chondrosarcoma of bone
Crossref DOI link: https://doi.org/10.1186/s12885-016-2522-8
Published Online: 2016-07-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peterse, Elisabeth F. P.
Cleven, Arjen H. G.
De Jong, Yvonne
Briaire-de Bruijn, Inge
Fletcher, Jonathan A.
Danen, Erik H. J.
Cleton-Jansen, Anne-Marie
Bovée, Judith V. M. G.
Funding for this research was provided by:
KWF Kankerbestrijding (UL2010-4873)
